The deal is exceptional.
Upfront payment circa $23 mill with a major global distributor.
Margins on manufacture which would be confidential
10% of the market size is $35 mill in sales where OCC will get a manufacturing margin
Validates the Celgro platform which the Remplir nerve repair product sits under an $8 Bill market
Let's not forget the ATI platform market for shoulder repair $3Bill market
Bring on more licensing deals with major players
Lots of money in the bank to do better deals
Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-33
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.5¢ |
Change
0.005(0.82%) |
Mkt cap ! $147.0M | |||
| Open | High | Low | Value | Volume |
| 61.5¢ | 62.0¢ | 61.0¢ | $428.7K | 696.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 142386 | 61.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 36604 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |